In fact, in one study, Momeni-Boroujeni et al. reported that, while ER and PR expression may be seen in some HGESS, the low ESR1 RNA expression may determine the limited efficacy of endocrine therapy in these tumours. This evidence concerns the gene PGR and neoplasm.